Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Rheumatology International|December 3, 2010
Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese populationShintaro Hara, Tomoko Henmi, Atsushi Kawakami, et al.
Modern Rheumatology|April 11, 2014
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Tomohiro Koga, Keita Fujikawa, et al.
The Journal of Rheumatology|April 19, 2011
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyYukiko Komano, Michi Tanaka, Toshihiro Nanki, et al.
Rheumatology (Oxford, England)|September 28, 2024
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registryYohei Kirino, Ayaka Maeda, Tomoyuki Asano, et al.
Clinical Chemistry|March 17, 2020
ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing EraYael Shinar, Isabella Ceccherini, Dorota Rowczenio, et al.
Modern Rheumatology|July 7, 2009
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese populationNaoki Iwamoto, Atsushi Kawakami, Keita Fujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2011
Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndromeKazuhiko Arima, Akira Kinoshita, Hiroyuki Mishima, et al.
Modern Rheumatology|October 9, 2025
High Glucocorticoid Dependency and Limited Therapeutic Response in Japanese Patients with VEXAS Syndrome: A Multicentre Retrospective StudyAyaka Maeda, Yohei Kirino, Naomi Tsuchida, et al.
Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Gain-of-function mutations in <i>ALPK1</i> cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndromeChristina Torres Kozycki, Shilpa Kodati, Laryssa Huryn, et al.
Pageof 14